210 related articles for article (PubMed ID: 37047148)
1. Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer.
Zhao X; Sakamoto S; Wei J; Pae S; Saito S; Sazuka T; Imamura Y; Anzai N; Ichikawa T
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047148
[TBL] [Abstract][Full Text] [Related]
2. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.
Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H
Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482
[TBL] [Abstract][Full Text] [Related]
5. Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective.
Pae S; Sakamoto S; Zhao X; Saito S; Tamura T; Imamura Y; Sazuka T; Reien Y; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
J Pharmacol Sci; 2022 Dec; 150(4):251-258. PubMed ID: 36344047
[TBL] [Abstract][Full Text] [Related]
6. Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.
Wang Q; Grkovic T; Font J; Bonham S; Pouwer RH; Bailey CG; Moran AM; Ryan RM; Rasko JE; Jormakka M; Quinn RJ; Holst J
ACS Chem Biol; 2014 Jun; 9(6):1369-76. PubMed ID: 24762008
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
Ohshima Y; Kaira K; Yamaguchi A; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yokobori T; Miyazaki T; Asao T; Tsushima Y; Kuwano H; Ishioka NS
Cancer Sci; 2016 Oct; 107(10):1499-1505. PubMed ID: 27465934
[TBL] [Abstract][Full Text] [Related]
8. Regulation of placental amino acid transporter activity by mammalian target of rapamycin.
Roos S; Kanai Y; Prasad PD; Powell TL; Jansson T
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C142-50. PubMed ID: 18987252
[TBL] [Abstract][Full Text] [Related]
9. Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.
Xu M; Sakamoto S; Matsushima J; Kimura T; Ueda T; Mizokami A; Kanai Y; Ichikawa T
J Urol; 2016 May; 195(5):1588-1597. PubMed ID: 26682754
[TBL] [Abstract][Full Text] [Related]
10. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
Saito S; Ando K; Sakamoto S; Xu M; Yamada Y; Rii J; Kanaoka S; Wei J; Zhao X; Pae S; Kanesaka M; Goto Y; Sazuka T; Imamura Y; Reien Y; Hamaguchi-Suzuki N; Saito S; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
Cancer Sci; 2024 Apr; ():. PubMed ID: 38655663
[TBL] [Abstract][Full Text] [Related]
11. Role of amino acid transporters in amino acid sensing.
Taylor PM
Am J Clin Nutr; 2014 Jan; 99(1):223S-230S. PubMed ID: 24284439
[TBL] [Abstract][Full Text] [Related]
12. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
Rii J; Sakamoto S; Mizokami A; Xu M; Fujimoto A; Saito S; Koike H; Tamura T; Arai T; Yamada Y; Goto Y; Sazuka T; Imamura Y; Suzuki K; Kanai Y; Anzai N; Ichikawa T
Cancer Sci; 2024 Mar; 115(3):937-953. PubMed ID: 38186218
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
Rii J; Sakamoto S; Sugiura M; Kanesaka M; Fujimoto A; Yamada Y; Maimaiti M; Ando K; Wakai K; Xu M; Imamura Y; Shindo N; Hirota T; Kaneda A; Kanai Y; Ikehara Y; Anzai N; Ichikawa T
Cancer Sci; 2021 Sep; 112(9):3871-3883. PubMed ID: 34050700
[TBL] [Abstract][Full Text] [Related]
14. LAT1-like transporters regulate dopaminergic transmission and sleep in Drosophila.
Aboudhiaf S; Alves G; Parrot S; Amri M; Simonnet MM; Grosjean Y; Manière G; Seugnet L
Sleep; 2018 Oct; 41(10):. PubMed ID: 30016498
[TBL] [Abstract][Full Text] [Related]
15. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H; Harada-Shoji N; Ebata A; Sato M; Soga T; Miyashita M; Tada H; Kawai M; Kosaka S; Onuki K; Usami S; Furumoto S; Hayashi S; Abe T; Suzuki T; Ishida T; Sasano H
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503187
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Thyroid Hormone Transport by l-Type Amino Acid Transporter.
Krause G; Hinz KM
Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):379-382. PubMed ID: 31739345
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia.
Jia X; Cao Y; Ye L; Liu X; Huang Y; Yuan X; Lu C; Xu J; Zhu H
Sci Rep; 2022 Mar; 12(1):4651. PubMed ID: 35301401
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise.
Drummond MJ; Fry CS; Glynn EL; Timmerman KL; Dickinson JM; Walker DK; Gundermann DM; Volpi E; Rasmussen BB
J Appl Physiol (1985); 2011 Jul; 111(1):135-42. PubMed ID: 21527663
[TBL] [Abstract][Full Text] [Related]
19. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
[TBL] [Abstract][Full Text] [Related]
20. L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells.
Satou M; Wang J; Nakano-Tateno T; Teramachi M; Suzuki T; Hayashi K; Lamothe S; Hao Y; Kurata H; Sugimoto H; Chik C; Tateno T
Mol Cell Endocrinol; 2020 Sep; 515():110868. PubMed ID: 32579901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
